
Nam V. Nguyen
Examiner (ID: 12891, Phone: (571)272-3061 , Office: P/2682 )
| Most Active Art Unit | 2682 |
| Art Unit(s) | 2685, 2612, 2684, 2682, 2635 |
| Total Applications | 1359 |
| Issued Applications | 980 |
| Pending Applications | 99 |
| Abandoned Applications | 302 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16157317
[patent_doc_number] => 20200216891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => NUCLEOSIDES AND NUCLEOTIDES WITH 3'-HYDROXY BLOCKING GROUPS
[patent_app_type] => utility
[patent_app_number] => 16/724088
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724088 | Sequencing methods using nucleotides with 3' AOM blocking group | Dec 19, 2019 | Issued |
Array
(
[id] => 17045184
[patent_doc_number] => 11098353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
[patent_app_type] => utility
[patent_app_number] => 16/722702
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 12
[patent_no_of_words] => 15590
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/722702 | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators | Dec 19, 2019 | Issued |
Array
(
[id] => 18701431
[patent_doc_number] => 11787930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Flow cell including a heteropolymer
[patent_app_type] => utility
[patent_app_number] => 16/721451
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 19040
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721451
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721451 | Flow cell including a heteropolymer | Dec 18, 2019 | Issued |
Array
(
[id] => 16893428
[patent_doc_number] => 11034964
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-15
[patent_title] => Binding molecules built from L-DNA with added nucleotides
[patent_app_type] => utility
[patent_app_number] => 16/719232
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3798
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719232 | Binding molecules built from L-DNA with added nucleotides | Dec 17, 2019 | Issued |
Array
(
[id] => 15866147
[patent_doc_number] => 20200140477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/714595
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16714595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/714595 | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway | Dec 12, 2019 | Issued |
Array
(
[id] => 17370380
[patent_doc_number] => 20220025432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHOD FOR FLUORESCENCE LABELING OF BIOLOGICAL MATERIALS, THERMALLY REMOVABLE FLUORESCENT LABELS FOR THIS METHOD, AND METHODS OF THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 17/311678
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311678 | METHOD FOR FLUORESCENCE LABELING OF BIOLOGICAL MATERIALS, THERMALLY REMOVABLE FLUORESCENT LABELS FOR THIS METHOD, AND METHODS OF THEIR PREPARATION AND USE | Dec 2, 2019 | Abandoned |
Array
(
[id] => 16177289
[patent_doc_number] => 20200224257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => QUENCHER AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/700618
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700618 | Quencher and use thereof | Dec 1, 2019 | Issued |
Array
(
[id] => 15649613
[patent_doc_number] => 20200087336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => LABELLED NUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 16/691108
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691108
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691108 | LABELLED NUCLEOTIDES | Nov 20, 2019 | Abandoned |
Array
(
[id] => 15931959
[patent_doc_number] => 20200157613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => CHROMOGENIC PEROXIDASE SUBSTRATES
[patent_app_type] => utility
[patent_app_number] => 16/688076
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688076 | Chromogenic peroxidase substrates | Nov 18, 2019 | Issued |
Array
(
[id] => 15711153
[patent_doc_number] => 20200102342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/687356
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16687356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/687356 | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway | Nov 17, 2019 | Issued |
Array
(
[id] => 15590441
[patent_doc_number] => 20200071755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => Methods and Compositions for Incorporating Nucleotides
[patent_app_type] => utility
[patent_app_number] => 16/674341
[patent_app_country] => US
[patent_app_date] => 2019-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16674341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/674341 | Methods and compositions for incorporating nucleotides | Nov 4, 2019 | Issued |
Array
(
[id] => 19579864
[patent_doc_number] => 12145960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Nucleotide analogues
[patent_app_type] => utility
[patent_app_number] => 17/287255
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 77581
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287255 | Nucleotide analogues | Oct 23, 2019 | Issued |
Array
(
[id] => 16230534
[patent_doc_number] => 10738072
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-08-11
[patent_title] => Nucleotide analogues
[patent_app_type] => utility
[patent_app_number] => 16/662781
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 77560
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/662781 | Nucleotide analogues | Oct 23, 2019 | Issued |
Array
(
[id] => 17998090
[patent_doc_number] => 11499186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => DNA sequencing by synthesis using modified nucleotides and nanopore detection
[patent_app_type] => utility
[patent_app_number] => 16/653278
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 26773
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 505
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16653278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/653278 | DNA sequencing by synthesis using modified nucleotides and nanopore detection | Oct 14, 2019 | Issued |
Array
(
[id] => 15769441
[patent_doc_number] => 20200115738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => MECHANICALLY-STRAINED OLIGONUCLEOTIDE CONSTRUCTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/601246
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16601246
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/601246 | Mechanically-strained oligonucleotide constructs and methods of using the same | Oct 13, 2019 | Issued |
Array
(
[id] => 15455135
[patent_doc_number] => 20200040392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => METHOD FOR LABELING OF ALDEHYDE CONTAINING TARGET MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/596539
[patent_app_country] => US
[patent_app_date] => 2019-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16596539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/596539 | Method for labeling of aldehyde containing target molecules | Oct 7, 2019 | Issued |
Array
(
[id] => 15741121
[patent_doc_number] => 20200109448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => LABELLED NUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 16/593512
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/593512 | LABELLED NUCLEOTIDES | Oct 3, 2019 | Abandoned |
Array
(
[id] => 18575778
[patent_doc_number] => 11732294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Polynucleotides, reagents, and methods for nucleic acid hybridization
[patent_app_type] => utility
[patent_app_number] => 16/590301
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 113
[patent_no_of_words] => 47000
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16590301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/590301 | Polynucleotides, reagents, and methods for nucleic acid hybridization | Sep 30, 2019 | Issued |
| 16/572078 | Directed transliteration of nucleotides in DNA | Sep 15, 2019 | |
Array
(
[id] => 16663857
[patent_doc_number] => 10933079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Oligonucleotide analogues incorporating 5-aza-cytosine therein
[patent_app_type] => utility
[patent_app_number] => 16/571564
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 22046
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/571564 | Oligonucleotide analogues incorporating 5-aza-cytosine therein | Sep 15, 2019 | Issued |